Skip to Content
Still using that old version of Internet Explorer? This site will work much better in a newer version of IE or Firefox.
Download Internet Explorer 8 or Firefox 3 now!

malaria

An Extended Follow up of a RTS,S/AS01E Malaria Vaccine Trial (MAL059)

Full Title: 
An Extended Follow up of a RTS,S/AS01E Malaria Vaccine Trial (MAL059)
Principal Investigator(s): 
Ally Olotu

Malaria is one of the leading causes of deaths in children below five years old.

Charles Newton

Charles Newton
Email: 
cnewtonatkilifi [dot] kemri-wellcome [dot] org
Group: 
Sickle Cell Disease (Dar es Salaam)

Charles Newton was born in Kenya, qualified in Cape Town, South Africa, with postgraduate training in Paediatrics in Manchester and London, United Kingdom.

Julie Makani

Julie Makani
Email: 
juliemakaniatyahoo [dot] com
Group: 
Sickle Cell Disease (Dar es Salaam)

Principle Investigator of the Sickle Cell Research Project

Sharon Cox

Email: 
Sharon [dot] Coxatlshtm [dot] ac [dot] uk
Group: 
Sickle Cell Disease (Dar es Salaam)

Qualifications:
1996 - BSc in Biochemistry - University College London - 1996
1997 - Post graduate teaching qualification - 1997

Brett Lowe

Brett Lowe
Email: 
blowe124atgmail [dot] com
Group: 
Sickle Cell Disease (Dar es Salaam)

Brett joined the Kilifi KEMRI-Wellcome programme in April 1992 and has been instrumental in the development of the programme's laboratory based research to its current status.

Francis Ndungu

francis-ndungu.jpg
Email: 
fndunguatkilifi [dot] kemri-wellcome [dot] org
Group: 
Molecular Parasitology and Immunology

Immunity to malaria is slow to develop, is non-sterilising and wanes rapidly when immune adults migrate to non-endemic regions, suggesting that specific problems exist in the establishment and main

Eunice W Nduati

Slide1.jpg
Email: 
enduatiatkilifi [dot] kemri-wellcome [dot] org
Group: 
Molecular Parasitology and Immunology

My initial work involved the search for potential inhibitors of the Plasmodium folate pathway and monitoring of drug resistance development to anti-folate anti-malarial drugs.

Effect of HIV infection on malaria specific antibodies

Full Title: 
The effect of HIV infection on the quantities and qualities of malaria specific antibodies

No description available.

Quality (avidity) of the antibody response to specific malaria antigens

Full Title: 
Is the quality (avidity) of the antibody response to specific malaria antigens associated with clinical protection?

No description available.

The human B cell response to malaria

Full Title: 
The human B cell response to malaria: are malaria-specific memory B cells in young children exposed to endemic malaria dysfunctional?

No description available.